Bulaquine
- Level
- Commodity
- Parent
- 51101900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101924This classification denotes an antimalarial agent with the molecular formula C21H27N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TSQ6U39Q3G, chemically known as 2(3h)-furanone, dihydro-3-(1-((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)ethylidene)- but generally known as bulaquine, which bears US NIH Compound Identifier 3036820. European Medicines Agency schedules Bulaquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00894MIG. The term BULAQUINE is an International Non-Proprietary Name. Most nations schedule bulaquine under HS 29349990 and SITC 51579. As of Q4 2014, BULAQUINE remains the US FDA Preferred Term for this commodity. Bulaquine bears US NLM identifiers UMLS ID C0082079 and NCI Concept Code C75997. SMILES: O1CC/C(=C(\NCCCC(NC2C3NCCCC3CC(OC)C2)C)C)C1=O.
Same parent
Under 51101900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.